Fostemsavir Tromethamine | ||||
CAS NO.: | 864953-39-9 | |||
Chemical Formula: | C29H37N8O11P | |||
Molecular Weight: | 704.6000 | |||
DMF&GMP status: | Please contact us for more details. | Description: |
Fostemsavir Tromethamine is an antiretroviral medication for adults living with HIV/AIDS who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations.
Fostemsavir is an HIV entry inhibitor and a prodrug of Temsavir (BMS-626529). Fostemsavir is a human immunodeficiency virus type 1 (HIV-1) gp120-directed attachment inhibitor. **The product protected by patents in this product catalog are used for laboratory analysis and development, and cannot be sold to any country or region with patent protection. If the resulting patent infringement risks and responsibilities will be borne by the buyer. |
|
Approvals | ||||
Active Ingredient | Dosage Form; Route | Strength | Proprietary Name | Applicant |
FOSTEMSAVIR TROMETHAMINE | TABLET EXTENDED RELEASE; ORAL | EQ 600MG BASE | RUKOBIA | VIIV HEALTHCARE CO |
Patent Data | ||||
Patent No. | Patent Expiration | Drug Substance Claim | Drug Product Claim | Patent Use Code |
7745625 | 11/19/2027 | DS | ||
8168615 | 02/25/2025 | DP | ||
8461333 | 02/25/2025 | DS | ||
Exclusive Data | ||||
Exclusivity Code | Exclusivity Expiration | |||
NCE | 07/02/2025 | |||